Objective: Aortic homografts offer many advantages over prosthetic valves. However, homograft dysfunction due to degeneration or infection may lead to reoperation. Aortic valve replacement in patients who have undergone previous aortic root replacement with an aortic homograft remains a technical challenge. To assess reoperation events a retrospective review was conducted. Materials and methods: From January 2000 to October 2006, 20 consecutive patients (38.8 AE 14.9 years old) underwent repeat surgery for aortic homograft failure. Results: Reoperation was performed 7.2 AE 3.5 years after implantation of the aortic homograft as a root. Indication was homograft degeneration (n = 18 [90%]) and endocarditis (n = 2 [10%]). In patients with major homograft wall calcifications or endocarditis, nine aortic root reconstructions were performed (Bentall procedure n = 7; homograft implantation n = 2). Each homograft was dissected with electrical cauterization and removed 'en-bloc' sparing the coronary buttons. In case of flexible homograft wall, stented prostheses (mechanical n = 10, bioprosthesis n = 1) were implanted along the homograft annulus. Additional procedures consisted of mitral valve replacements (n = 8), tricuspid repairs (n = 4), Konno procedure (n = 1) and coronary bypass (n = 5). Perioperative complications occurred in seven (35%) patients: sternal re-entry accident (n = 2); reoperations for mediastinitis (n = 1) or bleeding (n = 2); renal insufficiency (n = 1); total heart block (n = 1). No association was found between operative procedures and postoperative complications (Fisher's exact test). Two patients (10%) died from multiorgan failure in the early postoperative period. In total, 94.4% of the survivors remained free from reoperation at 74 months. Conclusion: Reoperation on patients with an aortic homograft as a root presents a relatively high perioperative morbidity. The surgical strategy depends on the degree of homograft wall calcification. #
Introduction
The aortic homograft, first implanted in 1962 by Sir Donald Ross [1] , offers many advantages over prosthetic valves: it obviates the need for anticoagulation, has excellent hemodynamics and a very low incidence of infection [2] . However, aortic homografts deteriorate over time at a variable rate depending on the patient's age, source of the homograft and the sterilization and preservation methods [3] . The degenerative tissue failure may lead to reoperation within 10-20 years [4] . Furthermore, aortic homograft dysfunction may also, in rare cases, be due to infection thus requiring replacement [5] . Many surgical techniques of aortic homograft implantation have been described [6] . Among them, the implantation of the homograft as a root with coronary ostia reimplantation has been recommended by many surgeons since this technique is considered to be a relatively simple and easily reproducible operation [7] .
During reoperation, degenerative and infective lesions, such as scars and calcification of the aortic homograft implanted as a root, may be responsible for increased technical difficulties. Aortic valve replacement in patients who have undergone previous aortic root replacement with an aortic homograft remains a challenging reoperation. We therefore evaluated our experience with aortic homografts as a root redo surgery to determine reoperation events.
Patients and methods

Patients
Between January 2000 and October 2006, 20 patients underwent redo surgery for aortic homograft failure in our institution. The aortic homograft had been implanted with the root replacement technique in all patients. The group's mean age was 38.8 AE 14.9 years (range 15; 68) and there were 16 male patients (80%).
Indications for repeat aortic surgery were homograft degeneration in 18 patients (90%) and endocarditis in two patients (10%). Five patients (25%) presented with a stenotic aortic homograft and a gradient of 33.2 AE 18 mmHg. Seven patients (35%) had aortic insufficiency (2.9 AE 0.6), and the remaining eight presented with mixed pathology. In all cases, the echocardiographic view of the aortic homograft showed either tears and/or calcifications of the cusps. Seven patients (35%) presented with complete aortic homograft calcification including the wall of the root.
Of the 20 patients, seven patients were undergoing their third or more operation. One patient had a mechanical aortic valve implanted on an aortic insufficiency, one patient had an aortic homograft implanted with the freehand technique, two patients underwent aortic valve repair, and the remaining three had a mitral valve repair prior to the implantation of the aortic homograft as a root. Homograft implantation was primarily performed in our institution in 13 cases. Indications for aortic homograft implantation were: endocarditis in 12 patients (60%), aortic insufficiency in seven patients (35%) and aortic dissection in one patient (5%). Endocarditis had occurred on a rheumatic aortic valve in eight patients (40%), on a mechanical valve in one patient (5%), on a previous aortic homograft implanted with the freehand technique in one patient (5%) and on a bicuspid aortic valve in two patients. The seven patients with aortic insufficiency suffered from rheumatic disease and the last patient with aortic dissection had Marfan disease. Patients' characteristics are reported in Table 1 .
Operative procedure
Surgery was performed through a median sternotomy under normothermic cardiopulmonary bypass. In patients with major homograft wall calcifications, the homograft was dissected with electrical cauterization and removed 'enbloc' sparing the coronary buttons. After cross-clamping the aorta and cardioplegia delivering, the ascending aorta was cross cut above the homograft. The homograft was separated cautiously from the pulmonary artery with electrical cauterization while checking the position of both coronary buttons from inside the homograft. Then, the coronary buttons were separated from the homograft using a scalpel. The remaining part of the homograft was removed from the patient using electrical cauterization. A total replacement of the aortic root with the modified Bentall-De Bono technique was performed in these cases. In case of endocarditis, the infected homograft was excised and all infected tissues were debrided. A new aortic homograft as a root was sutured in the natural position to facilitate coronary reimplantation.
In patients who presented flexible homograft wall, the homograft leaflets were excised and aortic valve prosthesis was sutured along the homograft annulus.
Follow-up and statistical analysis
Early follow-up was performed retrospectively by analyzing surgical files including echocardiography and long-term follow-up was carried out by mail or telephone contact.
Numerical variables were expressed as mean AE standard deviation. Ninety-five percent confidence intervals were computed for the categorical variables if suitable and statistical associations between categorical variables were analyzed with Fisher's exact test. Event free survival curves were made with the Kaplan-Meier method. A value of p < 0.05 was considered as significant.
Results
Procedures
Redo surgery was performed 7.2 AE 3.5 years (range 4; 168 months) after aortic homograft implantation as a root. A previous femoral cannulation was performed in two patients (10%) before the redo sternotomy. Sternal re-entry accident occurred in two patients (10%). In each case the aorta was adherent to the sternum bone and opened with the saw. In these patients, cardiopulmonary bypass was installed between the femoral artery and vein and opening of the chest was performed under hypothermia (18 8C) and circulatory arrest. These procedures were performed 4 and 79 months after homograft implantation and in both cases it was the first re-entry of the chest.
In patients who presented with major homograft wall calcifications or endocarditis, nine aortic root reconstructions were performed (Bentall-De Bono procedure n = 7; homograft implantation n = 2). Fig. 1 shows a picture of an explanted aortic homograft with major calcification. In case of a flexible homograft wall, stented prostheses (mechanical n = 10, bioprosthesis n = 1) were implanted along the homograft annulus. In one case, the surgeon could not reimplant the right coronary button and had to perform a right coronary bypass.
Additional procedures consisted of mitral valve replacements in 40% of the patients, tricuspid repairs in 20% and coronary bypass in 25% of the patients. One patient needed aortic annulus enlargement and a Konno procedure was performed.
Cardiopulmonary bypass time and aortic cross-clamp time were 163 AE 65 min and 104 AE 40 min, respectively. Characteristics of surgery and postoperative period are reported in Table 2 .
Hospital mortality and complications
Two patients (10%) died from multiorgan failure in the early postoperative period. Both patients presented a very long operative course (Bypass time >4 h) with major difficulties to remove the aortic homograft due to adherence. In both cases, right ventricular failure required a right coronary bypass and major bleeding characterized the surgery. Mechanical support such as extra corporeal membrane oxygenation and counter pulsation intra aortic balloon pump were unsuccessful.
Perioperative complications occurred in 35% of patients: sternal re-entry accident (10%); early reoperations for excessive bleeding and/or signs of cardiac tamponade (10%); reoperations for mediastinitis (5%); renal insufficiency necessitating dialysis (5%). One patient needed a permanent pacemaker for complete heart block (5%). Confidence intervals of 95% for postoperative complications are reported in Table 3 . We were not able to find any association between operative procedures and postoperative complications with Fisher's exact test (Table 3) .
Mean duration of hospitalization was 15.4 AE 14.4 days.
Survival
Follow-up was complete. Mean duration of follow-up was 2.1 AE 1.9 years (range: 74 months; 6 months). Fig. 2 shows Kaplan-Meier curves of the free-from-event survival for all patients as well as for survivors at the time of surgery. Cumulative free-from-event survival was 84.7% for all patients and 94.4% for the survivors at 74 months. One patient was reoperated on three months after redo procedure. An aortic homograft had been implanted in this patient for a Bartonella endocarditis. He presented a degenerated homograft with tears of the right coronary leaflets and was reoperated on 54 months later. The redo procedure consisted of implanting a stented bioprosthesis sutured along the homograft annulus. Three months later the patient presented with a large paravalvular leak necessitating a reoperation. The surgery consisted of the implantation of a stentless aortic valve (Cryolife, O'Brien 23) inside the homograft root. The patient was also treated for active Bartonella endocarditis with no bacteriological evidence. At 2 years, the patient was free from reoperation. There were no others complications during follow-up.
Discussion
Various authors consider aortic homografts as an ideal substitute for aortic replacement in young patients because of their superior hemodynamic performance, the absence of anticoagulation treatment and their low infection rate [8, 9] . The obvious drawbacks are their limited availability and a complicated implantation operative technique. However, surgery standardization together with an increased quality of care reduces the operative mortality for aortic homograft implantation [6, 7] .
Suboptimal durability is the most important factor leading to reoperation. Homograft degeneration is a long-term process and usually leads to leaflet perforation, fibrosis and calcification [10] . Patient's young age or donors older than 65 years were identified as the two risk factors that most likely contribute to degeneration [4, 11] . Aortic stenosis or insufficiency due to calcification and tears are the usual degenerative ways and were common among our patients [12, 9] . Most of the authors recommend early surgery of the failing homograft in order to limit the consequences on the left ventricle [11] [12] [13] [14] and thus, regular follow-up of the patient is needed to assess left ventricular function. Table 4 shows reoperation causes of aortic homografts in the literature [4, 10, 12, 15, 16] . Our study results support these reports, and indicate that the degenerative process was the primary reason for reoperation. As in our patients, infection is the second cause of aortic homograft reoperation. Timing of reoperation is usually 8-15 years after the initial surgery. In a series of 622 homografts, Sadowski reports a mean duration of 12 AE 4.54 years [9] . In the series of Lund et al. [4] , the absence of degeneration is 62% at 10 years and 18% at 20 years. Our patients were reoperated on 7.2 AE 3.5 years after the initial surgery that supports these findings.
The best surgical technique to avoid failure of an aortic homograft is to implant it as a functional unit (e.g. root replacement). This method decreases the risks of geometrical distortion due to technical error [4, 6, 17] . However, reoperating an aortic homograft implanted as a root may present technical difficulties. Besides the sternum reentry, the difficulties of the reoperation are due to the homograft calcification [18] . The calcification may affect the cusps, the homograft annulus and the homograft wall. Calcification can be so extensive that the aortic root becomes completely rigid. Thus, the strategy of the reoperation depends on the degree of homograft calcification. Eleven patients in our series presented minor calcifications of the root. In these cases, it was possible to dissect the flexible wall of the homograft and replace the aortic valve in the homograft. In case of major calcifications and a rigid wall of the homograft, the surgeon has to perform a root replacement (e.g. BentallDeBono procedure) [8, 13, 18] . We applied this strategy in seven patients who presented major calcifications of the root. Interestingly, as previously reported, the coronary buttons which constituted the native aortic wall, were never calcified and always remained flexible [12] .
The indications of redo surgery (degeneration or endocarditis) and numerous other factors (such as timing of reoperation, emergency surgery, age of the patient, comorbidities, associated procedures and left ventricular function) influence the prognosis of redo aortic valve replacement. In the literature, redo aortic valve replacement presents less risk than redo aortic root replacement [19, 20] . Davierwala et al. [19] reported 1.7% mortality in redo elective aortic valve replacement and in their study; mortality was not statistically related to redo surgery. In aortic root re-replacement, mortality between 8% and 12% was reported [21, 22] . In the literature, perioperative mortality for aortic homograft redo surgery is reported as between 3% and 8% [9, [11] [12] [13] . Kumar et al. [13] did not identify in their series an association between perioperative mortality and homograft redo surgery. In our series, we report two perioperative deaths (10%) and seven patients who presented perioperative complications. This high percentage of complications might be explained by the concomitant procedures. However, we did not find any statistical relationship between operative procedural characteristics and postoperative complications. The 95% confidence intervals computed for reopening surgeries or for all complications according to the procedure performed were always very large. Thus, these negative results were mainly a consequence of the small number of patients and clinical relevant difference cannot be excluded. We reported two sternal re-entry accidents. In each patient, the saw blade tore the aorta adherent to the sternum. The femoral vessels were cannulated and the chest opened under hypothermia (18 8C) during circulatory arrest. This technique is described for the surgery of a false aneurysm of the ascending aorta [15] . In some cases, a CT scan or a lateral chest X-ray shows the retro-sternal space and allows the surgeon to adapt his strategy [12] .
The aortic homograft redo-surgery remains a high-risk procedure compared to an elective aortic valve re-replacement. The degeneration of any aortic homograft is inevitable and at the time of initial implantation the surgeon must anticipate the reoperation. When comparing aortic homograft and mechanical prostheses, Kilian et al. [16] reported a higher rate of redo surgery in the homograft group.
The aortic homograft, due to its great resistance to infection, gives a clear advantage in endocarditis [5, 23] . According to the literature, aortic homografts present a small but constant infection rate [24] . Only two patients in our series were reoperated on for homograft infection. They presented with an abscess of the homograft annulus and we chose to implant a new aortic homograft. In patients who present annular abscess or prosthetic infection, the left ventricular outflow tract and the aortic root can be reconstructed with the aortic homograft. An abscess along the aorto-mitral junction can also be covered by the appending mitral leaflet of the aortic homograft [23] . Considering these reports, aortic endocarditis with annulus abscess or extensive prosthesis infection should be the main indications for aortic homograft implantation.
Limitations of the study
The major limitations of our study are its retrospective design and the small number of patients. There were various homografts sources and consequently the multiple preparation and preservation methods of the homografts may directly influence on the adherences within the pericardium as well as on the outcome.
Conclusion
The surgical strategy in aortic homograft root replacement depends on the degree of calcification of the homograft wall. In case of a flexible wall, the aortic valve prosthesis may be sutured along the aortic homograft annulus. In case of a calcified wall, an aortic root replacement must be performed. For these patients we recommend cautious dissection of the aortic homograft using electrical cauterization to remove 'en bloc' the diseased aortic homograft.
Late reoperation for failing aortic homograft implanted as a root remains a high-risk procedure. Considerable debate has surrounded the ideal methods of homograft implantation, with root replacement predominating from 1990s. However, subcoronary technique allows preserving the native sinuses and may facilitate an inevitable redo surgery. This more demanding and time-consuming technique requires precise matching of the valve size and root to avoid early failure [6] . A recent report of subcoronary implantation of aortic homograft presented extremely favorable early and late mortality, freedom from surgical reintervention and freedom from endocarditis [25] . Considering this report and the difficulties in redo surgery of aortic root homograft, the debate about subcoronary implantation may start again. Endocarditis with annulus abscess or major prosthesis infection should be the main indications of aortic homograft implantation as a root.
